PCN11 PHARMACOECONOMIC ANALYSES OF ERLOTINIB COMPARED WITH BEST SUPPORTIVE CARE (BSC) FOR THE TREATMENT OF RELAPSED NON-SMALL CELL LUNG CANCER (NSCLC) FROM THE CANADIAN PUBLIC HEALTH CARE PERSPECTIVE

✍ Scribed by I Côté; NB Leighl; M Gyldmark; B Maturi

• Book ID: 119594337
• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 66 KB
• Volume: 9
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)63441-9